EPISODE · Feb 6, 2020 · 1H 5M
30. Misconceptions and Marketing with Lupron and Orilissa
from In Sixteen Years of Endometriosis
Episode updated 8/2025. Amy and Brittany talk about how doctors are often misinformed about treatment for endometriosis, including the benefits, risks, and limitations of GnRh drugs. We discuss some ways pharmaceutical companies influence the doctor and/or the patient through marketing tactics, “awareness” campaigns, and more. 🔗RESOURCES🔗 For clickable links to the resources below, go to www.insixteenyears.com/episode30 🔗Lupron 🔗Orilissa ☀️CONNECT WITH AMY☀️ Instagram @in16yearsofendo Website: www.insixteenyears.com Like my show? Please rate it or leave a review! Support me by buying me a coffee: https://ko-fi.com/insixteenyears ⚠️DISCLAIMER⚠️ The information on my platforms is educational information only and not medical advice. Always check with your qualified medical professional before making any changes to your treatment plan. Keep in mind that while I strive to share evidenced-based information, this doesn’t always mean that my information is accurate or complete. Read my full disclaimer here: https://insixteenyears.com/disclaimer/
Embed this episode
NOW PLAYING
30. Misconceptions and Marketing with Lupron and Orilissa
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.